Methodological challenges of analysing COVID-19 data during the pandemic
Open Access
- 14 April 2020
- journal article
- editorial
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 20 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-NetIntensive Care Medicine, 2017
- Survival biases lead to flawed conclusions in observational treatment studies of influenza patientsJournal of Clinical Epidemiology, 2017
- Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelinesSystematic Reviews, 2016
- The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illnessCritical Care, 2016
- Developing Global Norms for Sharing Data and Results during Public Health EmergenciesPLOS Medicine, 2016
- Interpreting and comparing risks in the presence of competing eventsBMJ, 2014
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataThe Lancet Respiratory Medicine, 2014
- Avoidable statistical pitfalls in analyzing length of stay in intensive care units or hospitalsCritical Care, 2014
- Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of biasJournal of Clinical Epidemiology, 2012
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006